[{"type": "title", "data": "ONC Venous Thromboembolism (VTE) Treatment"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "For inpatient use only", "value": ""}, {"type": "note", "data": "No intramuscular injections", "value": ""}, {"type": "note", "data": "Avoid Aspirin, NSAIDs, celecoxib, ticlopidine, clopidogrel, dipyridamole and sulfinpyrazone ", "value": ""}, {"type": "note", "data": "For patient with platelet count less than 50 X 10^9/L consult hematology\n- Avoid dalteparin in patients with platelet counts less than 20 x 10^9/L \n- For platelet counts between 20 x 10^9/L and 50 x 10^9/L, may administer dalteparin 100 units/kg subcutaneous daily (Hematology consult recommended)\n- Transfuse patients with platelet count below 50 x 10^9/L\n- Stop dalteparin / warfarin / direct oral anticoagulants (DOACs) / other anticoagulants in case of major bleeding from any site, and inform the physician immediately", "value": ""}, {"type": "note", "data": "Inclusion Criteria:\n- 18 years of age or older\n- Acute venous thrombosis\n- Outpatient follow-up feasible", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Exclusion Criteria:\n- Clinically unstable for outpatient therapy\n- Active bleeding of clinical significance requiring intervention \n- Recent GI / GU bleed (one month), hemorrhagic stroke (three months), surgery or trauma (one month). Consider consulting Hematologist for discussion\n- Severe uncontrolled hypertension (systolic BP greater than or equal to 180 mmHg or diastolic BP greater than or equal to 110 mmHg)\n- Platelet count less than 50 x 10^9/L (consider Hematology consult) \n- If history of Heparin-Induced Thrombocytopenia (HIT), or allergy DO NOT give low molecular weight heparin (LMWH) or heparin. \n- If eGFR less than 30 mL/min or renal failure requiring dialysis\n- Liver failure with coagulopathy\n- Evidence of massive ileofemoral thrombosis\n- Require hospitalization for other reasons (e.g. pain control, dementia, poor social support)\n- Dalteparin is contraindicated if hypersensitivity to pork products\n- Hypersensitivity to Dalteparin or any of its constituents or to other low molecular weight heparins (LMWHs)", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Stop dalteparin / warfarin / other anticoagulants in case of major bleeding from any site, and inform physician immediately"}, {"type": "note", "data": "Dalteparin Treatment of DVT / PE", "value": ""}, {"type": "note", "data": "For body weight below 45 kg or greater than 145 kg please consult hematologist for dosing", "value": ""}, {"type": "order", "data": "dalteparin", "value": ""}, {"type": "sentence", "data": "10,000 unit, subcutaneous, qPM, drug form: syringe-inj"}, {"type": "sentence", "data": "12,500 unit, subcutaneous, qPM, drug form: syringe-inj"}, {"type": "sentence", "data": "15,000 unit, subcutaneous, qPM, drug form: syringe-inj"}, {"type": "sentence", "data": "18,000 unit, subcutaneous, qPM, drug form: syringe-inj"}, {"type": "sentence", "data": "10,000 unit, subcutaneous, q12h, drug form: syringe-inj"}, {"type": "sentence", "data": "12,500 unit, subcutaneous, q12h, drug form: syringe-inj"}, {"type": "note", "data": "For weight 101 to 115 kg, select both dalteparin below:", "value": ""}, {"type": "order", "data": "dalteparin", "value": ""}, {"type": "sentence", "data": "10,000 unit, subcutaneous, qAM, drug form: syringe-inj"}, {"type": "order", "data": "dalteparin", "value": ""}, {"type": "sentence", "data": "12,500 unit, subcutaneous, qHS, drug form: syringe-inj"}, {"type": "note", "data": "For weight 136 to 145 kg, select both dalteparin  below:", "value": ""}, {"type": "order", "data": "dalteparin", "value": ""}, {"type": "sentence", "data": "10,000 unit, subcutaneous, qAM, drug form: syringe-inj"}, {"type": "order", "data": "dalteparin", "value": ""}, {"type": "sentence", "data": "18,000 unit, subcutaneous, qHS, drug form: syringe-inj"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "Nursing to provide subcutaneous injection teaching"}, {"type": "note", "data": "PharmaCare Special Authority approval (1-877-657-1188) required for OUTPATIENT LMWH coverage", "value": ""}, {"type": "note", "data": "SmartSample card: 1 card / patient / admission supplied by VCC Pharmacy, prescription written by physician for acquisition of 5 free prefilled dalteparin syringes from Community Pharmacy", "value": ""}, {"type": "note", "data": "Warfarin Therapy", "value": ""}, {"type": "note", "data": "Start on day 1 of dalteparin therapy, if cross-over to warfarin therapy appropriate", "value": ""}, {"type": "note", "data": "Warfarin not recommended for majority of patients, unless daltaparin/DOACs therapy not an option. (E.g. Low renal function (creatinine less than 30) or financial difficulty)", "value": ""}, {"type": "note", "data": "Dalteparin and warfarin therapy must overlap at least 5 days, when INR has been therapeutic (target range = 2 to 3 for Acute DVT / PE) for 2 consecutive days then dalteparin must be discontinued", "value": ""}, {"type": "note", "data": "Recommended starting dose of warfarin is 5 mg PO. Subsequent warfarin orders to be written daily", "value": ""}, {"type": "order", "data": "warfarin", "value": ""}, {"type": "sentence", "data": "5 mg, PO, once, drug form: tab"}, {"type": "sentence", "data": "mg, PO, once, drug form: tab"}, {"type": "order", "data": "warfarin to Dose Daily", "value": ""}, {"type": "sentence", "data": "Nurse to call provider to notify of daily INR"}, {"type": "category", "data": "Laboratory"}, {"type": "note", "data": "Baseline labwork", "value": ""}, {"type": "order", "data": "CBC and Differential", "value": "checked"}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "CBC and Differential", "value": "checked"}, {"type": "sentence", "data": "Blood, AM Draw, Collection: T,N, once"}, {"type": "order", "data": "INR and PTT Panel", "value": "checked"}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Creatinine Level", "value": "checked"}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Alanine Aminotransferase", "value": "checked"}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Bilirubin Total", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Bilirubin Direct", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Electrolyte Panel (Na, K, Cl, CO2, Anion Gap)", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Urea", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "note", "data": "Ongoing labwork", "value": ""}, {"type": "order", "data": "CBC and Differential", "value": ""}, {"type": "sentence", "data": "Blood, AM Draw, Collection: T+1;0330, q3day"}, {"type": "order", "data": "INR", "value": ""}, {"type": "sentence", "data": "Blood, AM Draw, Collection: T+1;0330, qdaily"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "order", "data": "Pharmacy Consult", "value": ""}, {"type": "sentence", "data": "Reason for Consult: Med Teaching, For provision of anticoagulation patient counselling"}, {"type": "category", "data": "BCC Venous Thromboembolism (VTE) Treatment (Module)"}, {"type": "category", "data": "dalteparin 1"}, {"type": "category", "data": "Exactly"}, {"type": "category", "data": "2"}, {"type": "category", "data": "dalteparin"}, {"type": "category", "data": "dalteparin"}]
